• Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

  • Apr 26 2025
  • Length: 1 hr and 33 mins
  • Podcast

Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

  • Summary

  • Featuring perspectives from Ms Marianne J Davies, Dr Edward B Garon, Ms Marissa Marti-Smith and Dr Tiffany A Traina, including the following topics:

    • Introduction (0:00)
    • Overview of Antibody-Drug Conjugates (ADCs) (4:40)
    • Trastuzumab Deruxtecan (T-DXd) in Patients with HER2-Positive Metastatic Breast Cancer (mBC) with and without Brain Metastases (12:40)
    • Role of ADCs for Patients with ER-Positive mBC (35:09)
    • T-DXd in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) with HER2 Alterations (52:20)
    • Emerging Role of ADCs for Patients with Progressive EGFR-Mutant NSCLC (1:12:20)

    NCPD information and select publications

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.